ERAAP modulation: A possible novel strategy for cancer immunotherapy?

Doriana Fruci, Franco Locatelli, Loredana Cifaldi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Recent findings demonstrate that loss of ERAAP, an endoplasmic reticulum aminopeptidase involved in antigen processing, plays a key role in stimulating anti-tumor innate and adaptive immune responses. We show that MHC class I molecules produced in the absence of ERAAP retain their capability of presenting antigens to CD8(+) T cells, but not of inhibiting NK cells.
Lingua originaleEnglish
pagine (da-a)81-82
Numero di pagine2
RivistaOncoImmunology
Volume1
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • N/A

Fingerprint

Entra nei temi di ricerca di 'ERAAP modulation: A possible novel strategy for cancer immunotherapy?'. Insieme formano una fingerprint unica.

Cita questo